ImmunityBio, Inc. (IBRX)
2.22
-0.04
(-1.77%)
USD |
NASDAQ |
Dec 09, 16:00
2.22
0.00 (0.00%)
After-Hours: 20:00
ImmunityBio Market Cap: 2.187B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Hims & Hers Health, Inc. | 9.065B |
| Regeneron Pharmaceuticals, Inc. | 72.79B |
| Anixa Biosciences, Inc. | 166.56M |
| Iovance Biotherapeutics, Inc. | 893.18M |
| Summit Therapeutics, Inc. | 12.67B |
Market Cap Related Metrics
| PS Ratio | 23.01 |
| Price | 2.22 |
| Earnings Yield | -18.94% |